BioTech JNJ

Johnson & Johnson Announces Launch Of VARIPULSE Pro In Europe

April 07, 2026 — 08:33 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Johnson & Johnson (JNJ) announced the launch of VARIPULSE Pro in Europe following CE Mark approval. The VARIPULSE Pro Platform features a new pulse sequence designed to streamline procedures and enhance workflow efficiency. The company will feature the VARIPULSE Pro Platform at the European Heart Rhythm Association annual meeting.

"The introduction of VARIPULSE Pro in Europe reflects our commitment to advancing our PFA platforms through continuous innovation, enhancing procedural experience while maintaining the consistency and precision physicians expect from the VARIPULSE Platform," said Michael Bodner, Company Group Chair, Electrophysiology & Neurovascular, MedTech, Johnson & Johnson.

In pre-market trading on NYSE, Johnson & Johnson shares are up 0.03 percent to $240.97.

For More Such Health News, visit rttnews.com.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

BioTech
Stocks Mentioned
JNJ

Latest Articles
Data is currently not available